Twist Bioscience Corp Stock
Twist Bioscience Corp Stock
There is an upward development for Twist Bioscience Corp compared to yesterday, with an increase of €0.41 (1.100%).
With 12 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
At the moment Twist Bioscience Corp has reached the predicted target price of 38 €, with a current price of 37.93 €.
Criterium "Revenue growth" is seen as the biggest plus for Twist Bioscience Corp stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Twist Bioscience Corp in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Cons
?
M***** P*******
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Twist Bioscience Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Twist Bioscience Corp | 1.100% | -6.230% | -8.160% | 5.127% | 36.194% | 141.870% | -68.126% |
| Rockwell Medical Inc. | 0.130% | 3.634% | -9.091% | -48.803% | 13.821% | -41.667% | -93.694% |
| Pacira Pharmaceuticals | 0.000% | 8.511% | 11.475% | 3.030% | -5.556% | -43.017% | -66.000% |
| Savara Inc. | 0.430% | 2.212% | -1.282% | 83.333% | -12.830% | 136.802% | 263.780% |
Comments
Twist Bioscience (NASDAQ:TWST) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Show more
Ratings data for TWST provided by MarketBeat
Twist Bioscience (NASDAQ:TWST) had its "buy" rating reaffirmed by analysts at Guggenheim.
Show more
Ratings data for TWST provided by MarketBeat
Twist Bioscience (NASDAQ:TWST) had its price target raised by analysts at TD Cowen from $32.00 to $43.00. They now have a "buy" rating on the stock.
Show more
Ratings data for TWST provided by MarketBeat